PMC:7358770 / 36285-36522 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T339","span":{"begin":19,"end":26},"obj":"Body_part"},{"id":"T340","span":{"begin":139,"end":147},"obj":"Body_part"},{"id":"T341","span":{"begin":192,"end":200},"obj":"Body_part"}],"attributes":[{"id":"A339","pred":"fma_id","subj":"T339","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A340","pred":"fma_id","subj":"T340","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A341","pred":"fma_id","subj":"T341","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"rmation with IBV S protein as a model antigen and incubated with 100 nm AuNPs in a solution containing an optimized concentration of viral proteins [133]. As compared to inoculation with free proteins, vaccination with the sVLPs showed e"}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T391","span":{"begin":30,"end":31},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T392","span":{"begin":81,"end":82},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"rmation with IBV S protein as a model antigen and incubated with 100 nm AuNPs in a solution containing an optimized concentration of viral proteins [133]. As compared to inoculation with free proteins, vaccination with the sVLPs showed e"}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T544","span":{"begin":19,"end":26},"obj":"Chemical"},{"id":"T545","span":{"begin":38,"end":45},"obj":"Chemical"},{"id":"T546","span":{"begin":83,"end":91},"obj":"Chemical"},{"id":"T547","span":{"begin":139,"end":147},"obj":"Chemical"},{"id":"T548","span":{"begin":192,"end":200},"obj":"Chemical"}],"attributes":[{"id":"A544","pred":"chebi_id","subj":"T544","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A545","pred":"chebi_id","subj":"T545","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A546","pred":"chebi_id","subj":"T546","obj":"http://purl.obolibrary.org/obo/CHEBI_75958"},{"id":"A547","pred":"chebi_id","subj":"T547","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A548","pred":"chebi_id","subj":"T548","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"rmation with IBV S protein as a model antigen and incubated with 100 nm AuNPs in a solution containing an optimized concentration of viral proteins [133]. As compared to inoculation with free proteins, vaccination with the sVLPs showed e"}

    2_test

    {"project":"2_test","denotations":[{"id":"32679328-27552321-48281354","span":{"begin":149,"end":152},"obj":"27552321"},{"id":"T23570","span":{"begin":149,"end":152},"obj":"27552321"}],"text":"rmation with IBV S protein as a model antigen and incubated with 100 nm AuNPs in a solution containing an optimized concentration of viral proteins [133]. As compared to inoculation with free proteins, vaccination with the sVLPs showed e"}

    LitCovid-PMC-OGER-BB

    {"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T1011","span":{"begin":13,"end":16},"obj":"NCBITaxon:10376"},{"id":"T1012","span":{"begin":17,"end":26},"obj":"PG_1"},{"id":"T1013","span":{"begin":38,"end":45},"obj":"CHEBI:59132;CHEBI:59132"},{"id":"T1014","span":{"begin":83,"end":91},"obj":"CHEBI:75958;CHEBI:75958"},{"id":"T1015","span":{"begin":133,"end":138},"obj":"NCBITaxon:10239"},{"id":"T56434","span":{"begin":2,"end":10},"obj":"GO:0042571"},{"id":"T60371","span":{"begin":29,"end":36},"obj":"CL:0000214;UBERON:0002106"},{"id":"T45199","span":{"begin":37,"end":43},"obj":"CL:0000084;GO:0042110"},{"id":"T21004","span":{"begin":44,"end":52},"obj":"GO:0042110"},{"id":"T15497","span":{"begin":102,"end":107},"obj":"NCBITaxon:8782"},{"id":"T7796","span":{"begin":117,"end":128},"obj":"NCBITaxon:11118"},{"id":"T31634","span":{"begin":201,"end":209},"obj":"GO:0030674"},{"id":"T82150","span":{"begin":210,"end":215},"obj":"NCBITaxon:10239"},{"id":"T7983","span":{"begin":216,"end":224},"obj":"CHEBI:59132;CHEBI:59132"}],"text":"rmation with IBV S protein as a model antigen and incubated with 100 nm AuNPs in a solution containing an optimized concentration of viral proteins [133]. As compared to inoculation with free proteins, vaccination with the sVLPs showed e"}